¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Barrier Fenestrated Strl Field Misc"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blood-thymus barrier
    Ç÷¾×°¡½¿»ùÀ庮, Ç÷¾×Èä¼±À庮
  • mucosal barrier
    Á¡¸·À庮
  • osmotic barrier
    »ïÅõÀ庮
  • placental barrier
    ŹÝÀ庮
  • potential barrier
    ÀüÀ§À庮
  • permeability barrier
    Åõ°úÀ庮
  • somatic barrier
    ½ÅüÀ庮
  • sonic barrier
    À½ÆÄÀ庮
  • stimulus barrier
    ÀÚ±ØÀ庮
  • auditory field
    û°¢¹üÀ§, û¿ª
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • abutted field
    ÀÎÁ¢Á¶»ç¸é, Á¢ÃËÁ¶»ç¸é
  • B1 field gradient
    ȸÀüÀÚÀå±â¿ï±â
  • binocular field
    ¾ç¾È½Ã¾ß, µÎ´«½Ã¾ß
  • boost field
    Á¶»ç¿µ¿ª, Á¶»ç¸é
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mucosal barrier
    Á¡¸·À庮
  • osmotic barrier
    »ïÅõÀ庮
  • permeability barrier
    Åõ°úÀ庮
  • placental barrier
    ŹÝÀ庮
  • potential barrier
    ÀüÀ§À庮
  • somatic barrier
    ½ÅüÀ庮
  • sonic barrier
    À½ÆÄÀ庮
  • stimulus barrier
    ÀÚ±ØÀ庮
  • abutted field
    ÀÎÁ¢Á¶»ç¸é, Á¢ÃËÁ¶»ç¸é
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • auditory field
    û°¢¹üÀ§, û¿ª
  • geometric field distortion artifact
    ±âÇÏÇÐÀûÀÚÀå¿Ö°îÀΰø¹°
  • B1 field gradient
    ȸÀüÀÚÀå±â¿ï±â
  • binocular field
    ¾ç¾È½Ã¾ß, µÎ´«½Ã¾ß
  • boost field
    Á¶»ç¿µ¿ª, Á¶»ç¸é
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • frontal adversive field
    ÀüµÎ¿±´ëÃø¾ß(¡­Óßö´å¯), Àü¿îµ¿¿ª(îñê¡ÔÑæ´).
  • geometric field distortion artifact
    ±âÇÏÇÐÀû ÀÚÀå ¿Ö°î Àΰø¹°
  • geometric field separtion
    ±âÇÏÇÐÀûÁ¶»ç¿µ¿ªºÐ¸®
  • geometrical field
    ±âÇÏÇÐÀûÁ¶»ç¿µ¿ª
  • gradient magnetic field
    °æ»ç ÀÚ±âÀå
  • gravitational field
    Áß·ÂÀå(ñìæ³íÞ).
  • high field MR scanner
    °íÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • illumination, dark-field
    ¾Ï½Ã¾ßÁ¶¸í
  • point outside field
    Á¶»ç¿µ¿ª¹ÛÁöÁ¡
  • pulsed-field gel electrophoresis (PFGE)
    °£Çæ¾ß Àü±â¿µµ¿
  • radio-frequency field
    °íÁÖÆÄ ÀÚÀå
  • rectangular field of view (FOV)
    Á÷»ç°¢Çü ½Ã¾ß
  • relative field
    ºñ±³¿µ¿ª(ÝïÎòçÐæ´).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blood cerebrospinal fluid barrier
    Ç÷³úô¼ö¾×À庮, Ç÷¾×³úô¼ö¾×°ü¹®
  • blood cerebrospinal fluid barrier
    Ç÷³úô¼ö¾×À庮, Ç÷¾×³úô¼ö¾×°ü¹®.
  • blood gas barrier
    Ç÷¾×°¡½ºÀ庮(¡­î¡Ûú).
  • blood labyrinthine barrier
    Ç÷¾×³»ÀÌÀ庮
  • blood labyrinthine barrier
    Ç÷¾×³»ÀÌÀ庮(¡­Ò®ì¼î¡Ûú).
  • blood thymus barrier
    Ç÷¾×°¡½¿»ùÀ庮, Ç÷Èä¼±À庮.
  • blood- testis barrier
    Ç÷¾× °íȯ À庮(úìäûÍÂü¯î¡Ûý)
  • blood-aqueous barrier
    Ç÷¾×¹æ¼öÀ庮(¡­Û®â©î¡Ûú).
  • blood-brain barrier
    Ç÷¾×-³ú À庮
  • blood-brain barrier
    Ç÷³úÀ庮(úìÒàî¡Ûú)
  • blood-brain barrier = BBB
    Ç÷³úÀ庮(¡­Òàî¡Ûú)
  • blood-brain/cerebrospinal fluid barrier
    Ç÷-³ú/³úô¼ö¾× À庮.
  • blood-nerve barrier
    Ç÷½Å°æÀ庮(úìãêÌèî¡Ûú)
  • blood-ocular barrier
    Ç÷¾×¾È±¸À庮
  • blood-retinal barrier
    Ç÷¾×¸Á¸·À庮
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • electric field
    ÀüÀå(ï³íÞ) °ãÃþ(öµ)
  • field desorption mass spectrometry
    ÀåÅ»Âø Áú·®ºÐ±¤ÃøÁ¤¹ý (íÞ÷­ó·òõÕáÝÂÎÃö´ïÒÛö)
  • field effect
    ÀåÈ¿°ú(íÞüùÍý)
  • field flow fractionation
    Àå(íÞ)È帧 ºÐȹ¹ý(ÝÂüñÛö)
  • field inversion gel electrophoresis
    ÀåÀüµµ(íÞï´Óî) Á© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • field ionization mass spectrometry
    Àå(íÞ) ÀÌ¿ÂÈ­(ûù) Áú·®ºÐ±¤ÃøÁ¤¹ý(òõÕáÝÂÎÃö´ïÒÛö)
  • field ion microscope
    Àå(íÞ) À̿ Çö¹Ì°æ(úéÚ°Ìð)
  • ligand field theory
    ¸®°£µåÀå(íÞ) ÀÌ·Ð(ìµÖå)
  • linear electric field effect
    ¼±Çü Àü±âÀåÈ¿°ú(àÊû¡ï³Ñ¨íÞüùÍý)
  • magnetic field
    ÀÚÀå(í¸íÞ)
  • pulsed-field gel electrophoresis
    ÆÞ½ºÀå(íÞ) Á© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • sedimentation field flow fractionation
    ħ°­Àå(öØË½íÞ) È帧ºÐȹ¹ý(ÝÂüñÛö)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • field strength
    ÀÚÀå¼¼±â, ÀÚÀå·Â
  • field survey
    ÇöÁöÁ¶»ç
  • FOV [=field of view]
    ¿µ»ó¿µ¿ª, ¿µ»ó¹üÀ§
  • fringe field
    ÁÖº¯¾ß
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â
  • geometric field distortion artifact
    ±âÇÏÇÐÀûÀÚÀå¿Ö°îÀΰø¹°
  • gradient magnetic field
    °æ»çÀÚ±âÀå
  • high field MR scanner
    °íÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • horizontal field magnet
    ¼öÆò¸éÀÚ¼®
  • in-field-of-view saturation band
    ¿µ»ó¿µ¿ª³»Æ÷È­´ë
  • intermediate field MR scanner
    ÁßµîÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • irradiation field
    ¹æ»ç¼±Á¶»ç¾ß
  • low field MR scanner
    ÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • lung field
    Æó¾ß
  • magnet field homogeneity
    ÀÚÀå±ÕÁú¼º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BBB blood-brain barrier; blood buffer base; bundle-branch block
BBBD blood brain barrier disruption
BCB blood-cerebrospinal fluid barrier; brilliant cresyl blue
BIU barrier isolation unit
BR barrier reared [experimental animals]; baseline recovery; bathroom; bed rest; bedside rounds; biliru...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BTB Blood-Testis Barrier
BTB Blood-Tumour-Barrier
EBA Endothelial barrier antigen
BBBD blood brain barrier disruption
BNB blood nerve barrier
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • color field
    »ö ½Ã¾ß
  • constant field equation
    Á¤ÀüÀå ¹æÁ¤½Ä
  • cortical field
    ÇÇÁú ¿µ¿ª
  • dark-field microscope
    ¾Ï½Ã¾ß Çö¹Ì°æ
    ¾Ï½Ã¾ß Á¶¸í¹ý¿¡ ÀÇÇØ º¸ÅëÀÇ Çö¹Ì°æÀ¸·Î´Â º¸ÀÌÁö ¾Ê´Â ¹Ì¼¼ÇÑ ÀÔÀÚ¸¦ º¼ ¼ö ÀÖ´Â Çö¹Ì°æ. ÇÑ¿Ü Çö¹Ì°æÀ» ¸»Çϴµ¥, ¾Ï½Ã¾ß Á¶¸í°ú ±× Áý±¤ ·»Á »ç¿ëÇϹǷΠÀÌ¿Í °°ÀÌ ºÒ¸®±âµµ ÇÑ´Ù.
  • depository field
    ÷°¡ ¾ß
  • electromagnetic field
    ÀüÀÚÀå
    1. Àü±âÀå°ú ÀÚ±âÀåÀ» ÅëÆ²¾î ÁöĪÇÏ´Â ¸». 2. Àü±âÀå°ú ÀÚ±âÀåÀÌ ¼­·Î ¿¬°üµÇ¾î °°ÀÌ ³ªÅ¸³¯ ¶§ À̸£´Â ¸».
  • equivalent field
    µî°¡ Á¶»ç ¿µ¿ª
  • eye field
    ½Ã¾ß
  • far field
    ¿ø°Å¸® ±¸¿ª
  • field
    ±¸¿ª, ¾ß, ¿µ¿ª
    1. ÀÛ¿ë ¿µ¿ª ¶Ç´Â Àå¼Ò³ª °ø°£. 2. Áö½Ä, ¿¬±¸, Á÷¾÷¿¡ À־ÀÇ Àü¹® ºÐ¾ß. 3. ¹ß»ýÇп¡ ÀÖ¾î º¯µ¿ ¿äÀÎÀÇ ¹üÀ§ ³»¿¡¼­ ºÐÈ­ÇÏ´Â ¿µ¿ª.
  • field cancerization
    ±¸¿ª ¾ÏÈ­
  • field echo
    ÀÚÀå ¿¡ÄÚ
  • field inhomogeneity
    ÀÚÀå ºÒ±ÕÀÏ, ÀÚÀå ºÒ±ÕÀϼº
  • field profile
    ÀÚÀå Ãø¸é »ó
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
thermal barrier <radiobiology> In magnetic mirror devices, this is a depression of electrostatic potential formed by enhancing ion loss in the region between the central cell and the positive potential plug. The thermal barrier significantly reduces the density requirements in the plug and lowers the overall power required to sustain the solenoidal plugging by thermally decoupling central cell electrons from the end plugs.
(09 Oct 1997)
auditory field The space included within the limits of hearing of a definite sound, as of a tuning fork.
(05 Mar 2000)
bright field illumination <microscopy> The method of lighting the specimen with a solid cone of rays. Transmitted bright field illumination is performed by a substage condenser. Reflected bright field illumination is performed by a vertical illuminator.
Compare: dark field illumination
(05 Aug 1998)
bright field imaging <microscopy> An imaging mode in a transmission electron microscopy that uses only unscattered Electrons to form the image. Contrast in such an image is due entirely to mass-thickness variations in amorphous samples, and may include diffraction contrast in crystalline samples.
(05 Aug 1998)
bright field microscopy <technique> Optical microscopy, in which absorption to a great extent and diffraction to a minor extent give rise to the image, as opposed to phase contrast or interference methods of microscopy.
(18 Nov 1997)
Broca's field The posterior part of the inferior frontal gyrus of the left or dominant hemisphere, corresponding approximately to Brodmann's area 44; Broca identified this region as an essential component of the motor mechanisms governing articulated speech.
Synonym: Broca's area, Broca's field, motor speech centre.
(05 Mar 2000)
cardioid dark field condenser <microscopy> A condenser designed with two reflecting surfaces, the first, a spherical surface which reflects the rays to a second, cardioid (heart-shaped) surface. The virtue in such an arrangement is that, if the cardioid surface is of true figure, the lens is both achromatic and aplanatic. It has a limiting numerical aperture of about 1.0. Thus objectives of a greater numerical aperture cannot be used successfully with it. A true cardioid figure is the trace of a point on the circumference of a circle rolling around an equal, fixed circle.
(05 Aug 1998)
magnetic field The sphere of influence of a magnet.
(05 Mar 2000)
magnetic field gradient In magnetic resonance imaging, a magnetic field that varies with location, superimposed on the uniform field of the magnet, to alter the resonant frequency of nuclei and allow recovery of their spatial position.
Synonym: field gradient.
(05 Mar 2000)
paraboloid dark field condenser <microscopy> A lens of parabolic shape. The vertex end is ground back so that its focus can be brought into coincidence with the specimen on the slide. A central stop is provided to block the central rays. It is used chiefly for medium- power work.
(05 Aug 1998)
receptive field That part of the retina whose photoreceptors (rods and cones) pertain to a single optic nerve fibre. The response of a neuron to stimulation of its receptive field depends on the type of neuron and the part of the field that is illuminated; an "on-centre" neuron is stimulated by light falling at the centre of its receptive field and inhibited by light falling at the periphery; an "off-centre" neuron reacts in exactly the opposite fashion; that is, it is inhibited by light falling at the centre of its receptive field. In either case, the net response depends on a complex switching action in the retina. When an entire receptive field is equally illuminated, the response of receptors at the centre of the field predominates.
(05 Mar 2000)
visual field The area simultaneously visible to one eye without movement; often measured by means of a bowl perimeter located 330 mm from the eye.
(05 Mar 2000)
visual field test <ophthalmology> A test which measures the extent of visual field loss. This test may be performed by a number of methods including confrontation, tangent screen exam and automated perimetry.
Diseases that affect visual field include stroke, diabetes, hypertension, multiple sclerosis, glaucoma, hyperthyroidism, Jacob-Creutzfeldt disease and optic glioma.
(27 Sep 1997)
reversed-field pinch <radiobiology> A toroidal magnetic confinement scheme which could constitute an alternative to the Tokamak for building a fusion reactor. It is characterised by a magnetic field mostly generated by the plasma itself, with toroidal and poloidal components of comparable intensities, in contrast with the Tokamak where most of the field is toroidal and externally applied. The name of the configuration is given by the fact that the toroidal component of the magnetic field changes sign in the outer region of the plasma. The main attractivness of the Reversed Field Pinch is that, according to presently established scalings, it could reach ignition without the need of auxiliary heating.
(09 Oct 1997)
rice-field fever A febrile illness affecting workers in rice fields, reported in Po valley in Italy and in Sumatra, caused by infection with a species of Leptospira.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dark field
    (Çö¹Ì°æÀÇ) ¾Ï½Ã¾ß
  • dark field illumination
    ¾Ï½Ã¾ß Á¶¸í¹ý(Çö¹Ì°æ ½Ã·áÀÇ)
  • dark field microscope
    (±¤)ÇÑ¿Ü Çö¹Ì°æ;¾Ï½Ã¾ß Çö¹Ì°æ
  • electric field
    Àü°è
  • field
    µé;¹úÆÇ;¹ç;±¤Àå;Ç¥¸é;»êÁö;½Î¿òÅÍ;°æ±âÀå;³»(¿Ü)¾ß;ºÐ¾ß;¹ÙÅÁ;¿µ»ó¸é(coal field źÀü)
  • field allowance
    ÃâÁ¤ ¼ö´ç
  • field amvulance
    À̵¿¾ßÀüº´¿ø
  • field army
    ¾ßÀü±º
  • field artillery
    ¾ßÆ÷;¾ßÀüÆ÷º´
  • field bag
    =MUSETTE (BAG)
  • field battery
    ¾ßÆ÷´ë;¾ßÀüÆ÷º´ Áß´ë
  • field book
    Ãø·®ÀÚÀÇ ¾ß¿Ü ¼öø;äÁý ¸Þ¸ðÀå
  • field boot
    ¹«¸­±îÁö ¿À´Â ±ºÈ­
  • field capacity
    ³óÆ÷ ¿ë¼ö·®
  • field captain
    ÁÖÀå ¼±¼ö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á